1st Translational Research E-Conference: Chronic Lymphocytic Leukaemia
November 16-19, 2020
Chairs: Jennifer Brown (Boston), Paolo Ghia (Milan), Michael Hallek (Cologne)
This program is presented according to Central European Time (CET).
Please check the corresponding hours in your time zone.
Monday, November 16, 2020
13:50-14:00 Welcome
SESSION I – The genomic and epigenomic landscape of CLL and clinical consequences
Chairs: Jennifer Brown (Boston), Christopher Oakes (Columbus)
14:00-14:05 Introduction Jennifer Brown (Boston)
Christopher Oakes (Columbus)
14:05-14:20 Genetic predisposition Jennifer Brown (Boston)
14:20-14:35 Genetic landscape Cathy Wu (Boston)
14:35-14:50 Ibrutinib resistance Jennifer Woyach (Colombus)
14:50-15:05 Epigenetic landscape Christopher Oakes (Columbus)
15:05-15:20 Risk stratification in CLL Antonio Cuneo (Ferrara)
15:20-15:50 General Discussion
SESSION II – The role of BCR activation and signalling for CLL
Chairs: Paolo Ghia (Milan), Kostas Stamatopoulos (Thessaloniki)
15:50-15:55 Introduction Paolo Ghia (Milan)
Kostas Stamatopoulos (Thessaloniki)
15:55-16:10 BCR isotypes/autonomous signalling Hassan Jumaa (Ulm)
16:10-16:25 The latest news on stereotypes Kostas Stamatopoulos (Thessaloniki)
16:25-16:40 Novel BCR targets Andrew Steele (Southampton)
16:40-16:55 Next generation BTK inhibitors (covalent/non-covalent?) Anthony Mato (New York)
SHORT ORAL COMMUNICATION
16:55-17:02 Mutational landscape of CLL mice models
overexpressing aid identify proliferative-associated
tumor genes involved in leukemic progression Pablo Oppezzo (Montevideo)
17:02- 17:32 General discussion
1